Log in
Enquire now
‌

US Patent 9995733 Agents for treating disease

Patent 9995733 was granted and assigned to Biotest AG on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Biotest AG
Biotest AG
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99957330
Patent Inventor Names
Niklas Czeloth0
Gregor Schulz0
Holger Wallmeier0
Kirsten Völp0
André Engling0
Benjamin Daelken0
Chantal Zuber0
Christoph Bruecher0
...
Date of Patent
June 12, 2018
0
Patent Application Number
134832800
Date Filed
May 30, 2012
0
Patent Primary Examiner
‌
Eric S Dejong
0
Patent abstract

Provided are methods of screening to identify molecules capable of binding to CD4 and capable of activating CD4+CD25+ regulatory T cells. Further provided are antibodies and antibody fragments capable of activating CD4+CD25+ regulatory T cells and methods and uses involving the antibodies and fragments thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9995733 Agents for treating disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.